Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-13

Clinical Trial Update: Topical Application to Relieve Gout: Efficacy Trial & Safety (TARGETS) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating topical treatment for gout, reporting efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dyve Biosciences, Inc. | Conditions: Gout | Phase 2 | Status: COMPLETED